Vol. 22/No. 13 | OncologyLive

Emerging Immune Checkpoint Research Focuses on CD137

July 08, 2021


During the past decade, a growing number of PD-1/PD-L1 inhibitors gained FDA approval to treat a wide range of cancer types. Their stimulatory counterparts also emerged as sought-after anticancer targets but have proved much more challenging to manipulate therapeutically.

New Toolkit Aims to Help Employers Address Cancer Treatment

July 08, 2021

The National Comprehensive Cancer Network (NCCN) has launched a digital initiative to provide strategic approaches specifically geared toward employers who need to navigate a diagnosis of cancer among their staff.

Novel Combination May Break Outcomes Stalemate in Pancreatic Cancer

July 07, 2021

Clinical Insights

Therapeutic breakthroughs for patients with metastatic pancreatic cancer have eluded investigators for decades, with chemotherapeutic combination strategies serving as the insurmountable standard of care.

Reducing Burnout Requires an Organizational Response

July 05, 2021

A new study suggests that reducing physician burnout requires an organizational-level response that focuses on creating of a medical practice culture that value qualities such as teamwork, open communication, and process improvement.

Scientific Communication Requires a Course Correction

July 02, 2021

The overall picture related to COVID-19 in the Unites States is encouraging, and we might suspect that the American public would be relatively united with favorable views of efforts of public health officials and organizations at the national, state, and local levels to successfully control this terrible event and return us to our prepandemic state.

Adjuvant Advances Shine at ASCO 2021

July 01, 2021

Cover Story

Novel therapeutic strategies are poised to expand in adjuvant settings for patients with early-stage disease facing recurrence risks in the treatment paradigms for a range of tumor types after positive data from large phase 3 clinical trials were highlighted at the 2021 American Society of Clinical Oncology Annual Meeting